跳转至内容
Merck
  • Haloperidol for the treatment of nausea and vomiting in palliative care patients.

Haloperidol for the treatment of nausea and vomiting in palliative care patients.

The Cochrane database of systematic reviews (2009-04-17)
Paul Perkins, Saskie Dorman
摘要

Nausea and vomiting are common symptoms of patients with terminal, incurable illnesses and can be distressing. The primary objective of the review was to evaluate the efficacy and adverse events associated with the use of haloperidol for the treatment of nausea and vomiting in palliative care patients. Several electronic databases were searched including CENTRAL, MEDLINE, EMBASE, CINAHL and AMED, using relevant search terms and synonyms. Handsearching complemented electronic searches (using reference lists of included studies, relevant chapters and review articles). There were no language restrictions imposed. Database searching was performed between 2nd and 16th September 2007. Studies considered for inclusion were randomised controlled trials (RCTs) of haloperidol for the treatment of nausea or vomiting, or both, in any setting. The studies had to be conducted with adults receiving palliative care or suffering from an incurable progressive medical condition. Studies where nausea or vomiting, or both, thought to be secondary to pregnancy or surgery were excluded. Records from each of the electronic databases were imported into a bibliographic package and merged into a core database where titles, keywords and abstracts were inspected for relevance. If it was not possible to accept or reject an abstract with certainty, the full text of the article was obtained for further evaluation. The two review authors independently assessed studies in accordance with the inclusion criteria. There were no differences in opinion between authors with regard to assessment of studies. No RCTs were identified meeting the inclusion criteria. Twenty-six studies were considered but all were excluded from the review. We did not identify any RCTs exploring the effectiveness of haloperidol for nausea and vomiting in palliative care patients.

材料
货号
品牌
产品描述

Sigma-Aldrich
氟哌啶醇, powder
Supelco
Haloperidol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
USP
氟哌啶醇, United States Pharmacopeia (USP) Reference Standard
氟哌啶醇, European Pharmacopoeia (EP) Reference Standard
峰鉴别用氟哌啶醇, European Pharmacopoeia (EP) Reference Standard
系统适用性试验用氟哌啶醇, European Pharmacopoeia (EP) Reference Standard